Literature DB >> 1716615

Direct expression of Bordetella pertussis filamentous hemagglutinin in Escherichia coli and Salmonella typhimurium aroA.

C A Guzmán1, M J Walker, M Rohde, K N Timmis.   

Abstract

Nonfused (i.e., nonhybrid) filamentous hemagglutinin (FHA) of Bordetella pertussis was efficiently expressed in Escherichia coli K-12 and Salmonella typhimurium aroA at levels higher than those found in wild-type B. pertussis when the upstream signals of the gene were replaced and the translation initiation region was engineered to optimize translational efficiency. Inclusion of part of the C-terminal FHA open reading frame, whose translation product does not appear to be part of the major secreted species of FHA, was shown to be important in achieving protein expression in both E. coli and S. typhimurium aroA; removal of the downstream gene sequence abolished recombinant FHA production. The levels of expression observed varied widely according to the construct and host bacterium used.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1716615      PMCID: PMC258952          DOI: 10.1128/iai.59.10.3787-3795.1991

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  42 in total

1.  Polynucleotide phosphorylase and ribonuclease II are required for cell viability and mRNA turnover in Escherichia coli K-12.

Authors:  W P Donovan; S R Kushner
Journal:  Proc Natl Acad Sci U S A       Date:  1986-01       Impact factor: 11.205

2.  Cloning of the adenylate cyclase genetic determinant of Bordetella pertussis and its expression in Escherichia coli and B. pertussis.

Authors:  R M Brownlie; J G Coote; R Parton; J E Schultz; A Rogel; E Hanski
Journal:  Microb Pathog       Date:  1988-05       Impact factor: 3.738

3.  Genetical and functional organisation of the Escherichia coli haemolysin determinant 2001.

Authors:  N Mackman; J M Nicaud; L Gray; I B Holland
Journal:  Mol Gen Genet       Date:  1985

4.  Two trans-acting regulatory genes (vir and mod) control antigenic modulation in Bordetella pertussis.

Authors:  S Knapp; J J Mekalanos
Journal:  J Bacteriol       Date:  1988-11       Impact factor: 3.490

Review 5.  Pertussis vaccine: present status and future prospects.

Authors:  A Robinson; L I Irons; L A Ashworth
Journal:  Vaccine       Date:  1985-03       Impact factor: 3.641

6.  Inducible expression vectors incorporating the Escherichia coli atpE translational initiation region.

Authors:  B Schauder; H Blöcker; R Frank; J E McCarthy
Journal:  Gene       Date:  1987       Impact factor: 3.688

7.  Transposon vectors containing non-antibiotic resistance selection markers for cloning and stable chromosomal insertion of foreign genes in gram-negative bacteria.

Authors:  M Herrero; V de Lorenzo; K N Timmis
Journal:  J Bacteriol       Date:  1990-11       Impact factor: 3.490

8.  Production of recombinant Bordetella pertussis serotype 2 fimbriae in Bordetella parapertussis and Bordetella bronchiseptica: utility of Escherichia coli gene expression signals.

Authors:  M J Walker; C A Guzmán; M Rohde; K N Timmis
Journal:  Infect Immun       Date:  1991-05       Impact factor: 3.441

9.  A bacteriophage T7 RNA polymerase/promoter system for controlled exclusive expression of specific genes.

Authors:  S Tabor; C C Richardson
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

10.  TnphoA: a transposon probe for protein export signals.

Authors:  C Manoil; J Beckwith
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

View more
  6 in total

1.  Expression and immunogenicity of hemagglutinin A from Porphyromonas gingivalis in an avirulent Salmonella enterica serovar typhimurium vaccine strain.

Authors:  E Kozarov; N Miyashita; J Burks; K Cerveny; T A Brown; W P McArthur; A Progulske-Fox
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

2.  Antibody responses in the lungs of mice following oral immunization with Salmonella typhimurium aroA and invasive Escherichia coli strains expressing the filamentous hemagglutinin of Bordetella pertussis.

Authors:  C A Guzmán; R M Brownlie; J Kadurugamuwa; M J Walker; K N Timmis
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

3.  Purification and immunogenicity of a recombinant Bordetella pertussis S1S3FHA fusion protein expressed by Streptococcus gordonii.

Authors:  Song F Lee; Scott A Halperin; Jennifer B Knight; Aaron Tait
Journal:  Appl Environ Microbiol       Date:  2002-09       Impact factor: 4.792

4.  Specific lung mucosal and systemic immune responses after oral immunization of mice with Salmonella typhimurium aroA, Salmonella typhi Ty21a, and invasive Escherichia coli expressing recombinant pertussis toxin S1 subunit.

Authors:  M J Walker; M Rohde; K N Timmis; C A Guzmán
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

5.  Antibody responses in the serum and respiratory tract of mice following oral vaccination with liposomes coated with filamentous hemagglutinin and pertussis toxoid.

Authors:  C A Guzman; G Molinari; M W Fountain; M Rohde; K N Timmis; M J Walker
Journal:  Infect Immun       Date:  1993-02       Impact factor: 3.441

6.  Production and characterization of recombinant pertactin, fimbriae 2 and fimbriae 3 from Bordetella pertussis.

Authors:  Yinghua Xu; Yaying Wang; Yajun Tan; Huajie Zhang; Lijie Wu; Lichan Wang; Qiming Hou; Shumin Zhang
Journal:  BMC Microbiol       Date:  2009-12-29       Impact factor: 3.605

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.